Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?

Published on Sep 9, 2009in Dementia and Geriatric Cognitive Disorders2.31
· DOI :10.1159/000236015
C. Sevilla1
Estimated H-index: 1
P.E. Jiménez Caballero1
Estimated H-index: 1
+ 1 AuthorsM. González-Adalid1
Estimated H-index: 1
Background/Aims: A full comparison of the satisfaction with treatment using the current Alzheimer’s disease (AD) therapies from the perspective of caregivers has not yet been done.
105k CitationsSource
#1John T. O'Brien (University of Cambridge)H-Index: 133
#2Clive Holmes (University of Southampton)H-Index: 72
Last. Alistair BurnsH-Index: 98
view all 14 authors...
The British Association for Psychopharmacology coordinated a meeting of experts to review and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As before, levels of evidence were rated using accepted standards which were then translated into grades of recommendation A-D, with A having the strongest evidence base (from randomised controlled trials) and D the weakest (case studies or expert opinion). Current clinical diagnostic criteria for dementia have sufficien...
202 CitationsSource
#1Jerónimo SanchoH-Index: 3
#2Pilar PeñaH-Index: 2
Last. Javier Rejas (Pfizer)H-Index: 34
view all 6 authors...
Summary Purpose The purpose of this study was to ascertain health care and non-health care resources use in the past 12-months and to estimate the cost-of-illness in adult outpatients with drug-resistant epilepsy (DRE) in Spain. Methods A cross-sectional and retrospective study was designed. Whole nation representative participants (epilepsy and general neurological clinics) were selected at random, but patients with drug-resistant epilepsy were included consecutively. We choose the societal per...
51 CitationsSource
#1Miguel A. RuizH-Index: 22
#2Antonio PardoH-Index: 16
Last. J.L. ArangurenH-Index: 2
view all 6 authors...
Abstract Objective To develop and validate a multidimensional generic questionnaire measuring satisfaction with treatment with medicines. The questionnaire was designed to be used in chronic patients undergoing pharmacological treatment for any disease. Methods After a literature review and cognitive debriefing process with an expert panel of six members and 21 chronic patients in four focus groups, a preliminary instrument with 36 items grouped into six dimensions was developed. Three samples o...
128 CitationsSource
#1Richard A. Hansen (UNC: University of North Carolina at Chapel Hill)H-Index: 21
#1Richard A. Hansen (UNC: University of North Carolina at Chapel Hill)H-Index: 29
Last. Daniel E JonasH-Index: 4
view all 6 authors...
Pharmacologic treatments for Alzheimer’s disease include the cholinesterase inhibitors donepezil, galantamine, and rivastigmine. We reviewed their evidence by searching MEDLINE®, Embase, The Cochrane Library, and the International Pharmaceutical Abstracts from 1980 through 2007 (July) for placebo-controlled and comparative trials assessing cognition, function, behavior, global change, and safety. Thirty-three articles on 26 studies were included in the review. Meta-analyses of placebo-controlled...
486 Citations
#1Mucha LH-Index: 1
#2Shaohung SH-Index: 1
Last. Del Valle MH-Index: 1
view all 6 authors...
BACKGROUND: Sustained treatment with a cholinesterase inhibitor (ChEI) is used in the management of the symptoms of Alzheimer’s disease (AD). However, the characteristic declines in learning and memory seen in AD may erode the patient’s ability to adhere to medication regimens with or without caregiver support. OBJECTIVES: To examine differences by type of ChEI in (1) monthly prevalence of use, (2) nonpersistence, (3) switching from the index drug to another ChEI, (4) number of days on therapy, ...
80 CitationsSource
#1Martin R. Farlow (IU: Indiana University)H-Index: 92
#2Michael L. MillerH-Index: 6
Last. Vojislav PejovicH-Index: 10
view all 3 authors...
Alzheimer’s disease (AD) is becoming an increasingly heavy burden on the society of developed countries, and physicians now face the challenge of providing efficient treatment regimens to an ever-higher number of individuals affected by the disease. Currently approved anti-AD therapies – the cholinesterase inhibitors and the N-methyl- D -aspartate receptor antagonist memantine – offer modest symptomatic relief, which can be enhanced using combination therapy with both classes of drugs. Additiona...
121 CitationsSource
: Diagnosis and treatment of dementia in nursing homes and assisted living facilities remains challenging since response to treatment and disease course varies for the common degenerative dementias. Four cholinesterase inhibitors and an N-methyl-D-aspartate glutamate receptor antagonist are approved by the US Food and Drug Administration for the treatment of Alzheimer's disease (AD). Treatment with AD medications is clinically efficacious and associated with reduced caregiver burden. Some contro...
9 Citations
#1Margaret Rothman (Johnson & Johnson)H-Index: 28
#2Philippe BeltranH-Index: 1
Last. Bonnie Teschendorf (Johnson & Johnson)H-Index: 1
view all 5 authors...
Abstract There is a broad agreement that patient-reported outcome (PRO) assessment in health care should proceed from a strong conceptual basis, with rationales clearly articulated in advance concerning what is to be measured and how this is to be accomplished. The representation of the patient's perspective has been part of clinical trials for some time; but the formalization of, and broader emphasis on PROs has become increasingly important with the release of the draft guidance for industry o...
226 CitationsSource
#1R. B. NettH-Index: 1
#2P. J. Tiseo (Pfizer)H-Index: 1
Last. Carolyn R. Sikes (Pfizer)H-Index: 13
view all 4 authors...
SUMMARY Objective: The efficacy of triptans for acute migraine has been well established in clinical trials but not in primary care, where they are most commonly prescribed. The aim of this open-label study was to evaluate the effectiveness of eletriptan 40 mg in primary care, using a patient-weighted satisfaction scale. Methods: Eligible patients met International Headache Society criteria for migraine, with 1‐6 attacks per month. Patients completed questionnaires at screening and following a s...
13 CitationsSource
Cited By19
#1S. del Rio-Sancho (UNIL: University of Lausanne)H-Index: 5
#1S. del Río-Sancho (UNIL: University of Lausanne)H-Index: 2
Last. A. López-CastellanoH-Index: 12
view all 9 authors...
Abstract Memantine is a non-competitive N -methyl- d -aspartate (NMDA) receptor antagonist used in the treatment of moderate to severe dementia including the symptoms of Alzheimer’s disease (AD). It is administered orally but compliance, swallowing problems and the routine use of multiple medications in elderly AD patients means that an alternative route of administration would be of interest. The aim of the present study was to develop memantine hydrochloride occlusive transdermal therapeutic s...
11 CitationsSource
#1S. A. Zhivolupov (Kirov Military Medical Academy)H-Index: 1
#2N. A. Rashidov (Kirov Military Medical Academy)H-Index: 1
Last. E. V. JakovlevH-Index: 1
view all 4 authors...
To evaluate the cognitive changes in patients with mild to moderate Alzheimer's disease after the treatment with acetylcholinesterase inhibitors - neuromidin and galantamine.Fifty-eight patients with probable Alzheimer's disease, aged 60-84 years (mean 73.2±6.7), were enrolled in a 20-week double-blind parallel group study. All patients were randomized in 2 groups: group 1 (n=28) received neuromidin, group 2 (n=30) - galantamine. Treatment efficacy was evaluated with the ADAS-cog/11 scale.Both d...
1 CitationsSource
#1Fang Liu (University of Hertfordshire)H-Index: 17
#2Sejal R. Ranmal (UCL: University College London)H-Index: 9
Last. Catherine Tuleu (UCL: University College London)H-Index: 23
view all 8 authors...
Patient acceptability of a medicinal product is a key aspect in the development and prescribing of medicines. Children and older adults differ in many aspects from the other age subsets of population and require particular considerations in medication acceptability. This review highlights the similarities and differences in these two age groups in relation to factors affecting acceptability of medicines. New and conventional formulations of medicines are considered regarding their appropriatenes...
110 CitationsSource
#1Meng-Shan Tan (Ocean University of China)H-Index: 48
#2Lan Tan (Ocean University of China)H-Index: 73
Last. Jin-Tai Yu (UCSF: University of California, San Francisco)H-Index: 77
view all 7 authors...
Increasing evidence has shown the aberrant expression of inflammasome-related proteins in Alzheimer's disease (AD) brain; these proteins, including NLRP1 inflammasome, are implicated in the execution of inflammatory response and pyroptotic death. Although current data are associated NLRP1 genetic variants with AD, the involvement of NLRP1 inflammasome in AD pathogenesis is still unknown. Using APPswe/PS1dE9 transgenic mice, we found that cerebral NLRP1 levels were upregulated. Our in vitro studi...
122 CitationsSource
#1Yunbo Chen (GU: Guangzhou University)H-Index: 3
#2Gang Wei (GU: Guangzhou University)H-Index: 3
Last. Dong-Feng Chen (GU: Guangzhou University)H-Index: 6
view all 17 authors...
Abstract β-Asarone is an active component of the Acori graminei rhizome that is a traditional Chinese medicine clinically used in treating dementia in China. However, the cognitive effect of β-asarone and its mechanism has remained elusive. Here, we used asenescence-accelerated prone 8 (SAMP8) mice, which mimic many of the salient features of Alzheimer׳s disease (AD), to further investigate whether modulation of the ROCK signaling pathway and/or autophagy, synaptic loss is involved in the effect...
24 CitationsSource
#1Anthony J. Veloso (U of T: University of Toronto)H-Index: 12
#2Paul M. Nagy (U of T: University of Toronto)H-Index: 3
Last. Kagan Kerman (U of T: University of Toronto)H-Index: 62
view all 9 authors...
Abstract The utility of a simple, low-cost detection platform for label-free electrochemical characterization of acetylcholinesterase (AChE) inhibition is demonstrated as a potential tool for screening of small-molecule therapeutic agents for Alzheimer's disease (AD). Technique validation was performed against the standard Ellman's colorimetric assay using the clinically established cholinesterase inhibitor (ChEI), Donepezil (Aricept ® ). Electrochemical measurements were obtained by differentia...
11 CitationsSource
Background and Aims: Poor adherence to anti-dementia drugs is common among patients with Alzheimer’s disease. This study evaluated whether caregivers were more sa
27 CitationsSource
#1Gang Wei (GU: Guangzhou University)H-Index: 3
#2Yunbo Chen (GU: Guangzhou University)H-Index: 3
Last. Hui Nie (GU: Guangzhou University)H-Index: 2
view all 13 authors...
Abstract β-Asarone, an active component of the Acori graminei rhizome that has been used as traditional Chinese herb, has been reported to be capable of inhibiting neuronal apoptosis. However, the signaling mechanism underlying the inhibitory effect of β-asarone has remained elusive. This study was aimed to investigate whether the CaMKII signaling pathway is involved in the β-asarone mediated neuroprotection. Using PC12 cells and primary cultures of cortical neurons treated with amyloid-β (Aβ)(1...
38 CitationsSource
#1Yoko NanaumiH-Index: 5
#2Mitsuko Onda (Osaka University of Pharmaceutical Sciences)H-Index: 5
Last. Yukio ArakawaH-Index: 9
view all 8 authors...
Objective: The objective of the study was to identify factors related to donepezil medication adherence ("adherence") of cognitively impaired patients in community pharmacies. Methods: One hundred and twenty community pharmacies in 28 regions in Japan were randomly selected. Questionnaires were mailed to these pharmacies. The pharmacists answered based on the medication profiles ("YAKUREKI") of the patients given donepezil at their pharmacies. The survey items were "adherence", "who is the key p...
1 CitationsSource
#2M. Sastre PazH-Index: 2
Last. S. Martín SánchezH-Index: 2
view all 3 authors...
Abstract Introduction Primary care (PC) and general neurology clinics (NC) assume the leading role in the health care of patients with dementia. There are hardly any studies on the satisfaction of the caregiver at these settings of health care. Methods A questionnaire was designed and distributed to 75 caregivers of patients with dementia who were reviewed in an NC and who had been referred from PC. The questionnaire included questions associated with the care, the use of services, and satisfact...
4 CitationsSource